Advestra advised eMolecules and Avista Healthcare Partners (of which eMolecules is a porfolio company), on the acquisition of all shares in Synple Chem. The acquisition strategically expands eMolecules’ product and service portfolio to
Advestra advised eMolecules and Avista Healthcare Partners (of which eMolecules is a porfolio company), on the acquisition of all shares in Synple Chem. The acquisition strategically expands eMolecules’ product and service portfolio to